RE: Open Orphan’s pipeline at the highest its ever been says @TMSreach12 May 2022 08:55
Quoted.
And it’s this part of the business that new chief executive Mo Khan predicts will be the driver of growth for the company that wants to be a “true” specialist contract research organisation, and one increasingly recognised by ‘Big Pharma’ and biotechs as the world leader in vaccine and antiviral testing using human challenge clinical trials.
Orphan’s early foray into Covid challenge studies has extended to malaria bringing the total challenge models to eight, and Khan talks about at least one good phone call a week from clients relating to one or all of the company’s capabilities and capacity.